1. Home
  2. LCTX vs CODI Comparison

LCTX vs CODI Comparison

Compare LCTX & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.51

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Logo D/B/A Compass Diversified Holdings Shares of Beneficial Interest

CODI

D/B/A Compass Diversified Holdings Shares of Beneficial Interest

HOLD

Current Price

$5.79

Market Cap

480.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCTX
CODI
Founded
1990
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
480.8M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
LCTX
CODI
Price
$1.51
$5.79
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$6.00
$8.00
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
03-05-2026
02-26-2026
Dividend Yield
N/A
4.30%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,556,000.00
N/A
Revenue This Year
$55.75
$0.93
Revenue Next Year
$2.96
$6.35
P/E Ratio
N/A
N/A
Revenue Growth
53.24
N/A
52 Week Low
$0.37
$4.58
52 Week High
$2.09
$20.01

Technical Indicators

Market Signals
Indicator
LCTX
CODI
Relative Strength Index (RSI) 33.23 35.75
Support Level $0.94 $5.30
Resistance Level $1.84 $7.04
Average True Range (ATR) 0.11 0.42
MACD -0.04 -0.18
Stochastic Oscillator 2.06 1.17

Price Performance

Historical Comparison
LCTX
CODI

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: